Delivery Order SPE2DB22D1017-SPE2DB25FYPSH
- Not listed
- The Defense Logistics Agency awarded a $1,315.62 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram units. This non-set-aside contract represents a single delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The point of performance is located at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $6,211.59 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Estradiol 0.01% cream in 42.5-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,072.08 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,864.28 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The award utilized no set-aside designation, indicating competitive selection among...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on September 19, 2025, with a ceiling value of $1,114.92 and an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Estrace 0.01% Cream in 42.5-gram units, with a ceiling value of $2,357.79 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram quantities. This firm fixed-price delivery order, valued at $1,255.56, represents a non-competitive set-aside transaction and is scheduled for completion by August 26, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Estrace 0.01% Cream in a 42.5-gram quantity. This firm fixed-price delivery order, valued at $5,201.20, represents a non-competitive set-aside procurement and is scheduled for completion by July 23, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,418.19 to AmerisourceBergen Drug Corp for Estrace 0.01% cream (42.5 grams) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's status as a child contract under the company's broader Indefinite...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPSHDelivery Order
The Defense Logistics Agency awarded a $2,676.81 delivery order to AmerisourceBergen Drug Corp for 42.5 grams of Estradiol 0.01% cream on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare procurement through its comprehensive pharmaceutical and medical supply portfolio. The parent IDC functions as a global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems worldwide. This delivery order represents a routine pharmaceutical procurement fulfilling the military health system's ongoing medical supply requirements under the established prime vendor contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/2/25 |